Insider selling at BellRing Brands, particularly when share price was low, is discouraging. The absence of insider buying in the past year and recent selling activity calls for caution. Despite profit growth, the history of sales warrants careful consideration before purchasing stock.
The CEO, Darcy Davenport, expressed increased confidence in the full year due to a strong start to 2024, which led to the decision to raise the company's outlook.
BellRing Brands and Olaplex outperformed expectations last quarter, while Nu Skin and Estée Lauder fell short. Overall, the personal care sector remains resilient with shares up 16.9%.
CEO Darcy Davenport reports strong momentum across BellRing Brands (BRBR), attributing profitable winds to the convenient nutrition category, and foresees bright future for the company.
Gainers: •$SpringWorks Therapeutics(SWTX.US)$+19.2% (Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase3DeFi Trial ) •$Roivant Sciences(ROIV.US)$+7.1% (FDA has approved VTAMA (tapinarof) cream) •$Ocugen(OCGN.US)$+5.9% (announces that it is diversifying its innovative pipeline by introducing a Phase 3 cell therapy platform technology called Ne?Cart) •$Skyline(SKY.US)$+4.4% (In reaction to earnings) •$网易(NTES.US)$+4.1% (In...
According to the disclosure of the US Securities and Exchange Commission (SEC),$贝莱德(BLK.US)$, the world's largest asset management company, submitted a position report (13F) for the first quarter (Q1) ended March 31, 2022. From the perspective of position preference BlackRock favors technology stocks, accounting for 24.78% of the total position. It was followed by financials and healthcare stocks, which acco...
BellRing Brands股票讨论区
In reaction to earnings/guidance:
• $GoodRx(GDRX.US)$ +38.5%, $EDGIO(EGIO.US)$ +13.5%, $Lemonade(LMND.US)$ +10.7%, $Desktop Metal(DM.US)$ +8.5%, $ShockWave Medical(SWAV.US)$ +8.2%, $Pubmatic(PUBM.US)$ +8.1%, $Olaplex(OLPX.US)$ +7%, $Vivid Seats(SEAT.US)$ +6.4%, $Noble(NE.US)$ +6.3%, $艾斯本科技(AZPN.US)$ +5.4%, $艾伦建材(AAON.US)$ +5%, $Hudbay Minerals(HBM.US)$ +5%, $Vivint Smart Home(VVNT.US)$ +4.9%, $Vivint Smart Home(VVNT.US)$ +4...
• $SpringWorks Therapeutics(SWTX.US)$ +19.2% (Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase3DeFi Trial )
• $Roivant Sciences(ROIV.US)$ +7.1% (FDA has approved VTAMA (tapinarof) cream)
• $Ocugen(OCGN.US)$ +5.9% (announces that it is diversifying its innovative pipeline by introducing a Phase 3 cell therapy platform technology called Ne?Cart)
• $Skyline(SKY.US)$ +4.4% (In reaction to earnings)
• $网易(NTES.US)$ +4.1% (In...
From the perspective of position preference
BlackRock favors technology stocks, accounting for 24.78% of the total position. It was followed by financials and healthcare stocks, which acco...
暂无评论